It's the first GLP-1 pill approved for treating obesity.
Man down in the Oval Office.
A new analysis finds that the heart-protecting benefits of semaglutide are largely independent of its weight loss effects.
The pharmaceutical company alleges Hims is widely selling cheaper versions of its blockbuster drugs, despite the FDA's recent mandate. Hims pushed back against the accusation.
Popular weight loss drugs promise to slim waistlines and improve our general health, but they also come with some unpleasant side effects involving our face, mouth, and teeth.
Lars Fruergaard Jørgensen is out.
Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose weight—without the nauseating symptoms now commonly seen with GLP-1 drugs.
The rate of adult obesity has finally stopped climbing in recent years, new CDC data shows.
Scientists have developed a gel-based version of semaglutide that could reduce how often people need to take it.
